Listed by the USPTO as JEAN-LOUIS, SAMIRA JM
Tech Center 1600 • Art Units: 1617 1627 1642 1644 1645
This examiner grants 61% of resolved cases
JEAN-LOUIS, SAMIRA JM is assigned to tech center 1600 and art unit 1617. The profile covers 980 resolved cases, with a 60.9% allowance rate and a median of 1061 days to allowance. The 45.4% interview lift makes examiner interviews an important consideration in prosecution planning for this docket. Applicants can use the figures to evaluate whether interview preparation should accompany claim amendments and written technical explanations.
The listed companies are Empathbio Inc., Regents of the University of Minnesota, and Reistone Biopharma Company Limited. The associated firms are COOLEY LLP, NIXON & VANDERHYE, PC, and Taft Stettinius & Hollister LLP. Their work offers a relevant reference set for biotechnology and pharmaceutical filings in art unit 1617.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18722474 | MITOCHONDRIAL ATP INHIBITORS TARGETING THE GAMMA SUBUNIT PREVENT METASTASIS | Non-Final OA | LUNELLA BIOTECH, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy60.9% of resolved applications examined by Samira Jm Jean-Louis were allowed (980 resolved cases), compared with 34.1% across Art Unit 1617 over the last five years.
This examiner's interview lift is +45.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Samira Jm Jean-Louis took 1,061 days on average from filing to allowance.
Samira Jm Jean-Louis examines applications in Art Unit 1617 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
